Cancer immunotherapy is an advanced treatment approach that activates the patient's immune system to combat tumor cells. Unlike conventional methods (chemotherapy, radiation therapy), immunotherapy utilizes natural immune mechanisms to recognize and destroy cancer.
—Immune Checkpoint Inhibitors Drugs (e.g., pembrolizumab, nivolumab) block proteins that prevent immune cells from attacking tumors (e.g., PD-1, CTLA-4).
—CAR T-cell Therapy Patient's T-lymphocytes are genetically modified to recognize and eliminate cancer cells.
—Monoclonal Antibodiesа Targeted antibodies (e.g., rituximab, trastuzumab) specifically bind to proteins expressed by cancer cells.
— Cytokines and Immunostimulants Proteins (e.g., interleukins, interferons) enhance immune system activity against cancer.
— Cancer Vaccines Stimulate immune response against tumor-specific antigens (e.g., Sipuleucel-T vaccine for prostate cancer).
—High Specificity Targets tumors while sparing healthy tissues.
—Long-term Protection Immune system develops memory against cancer cells, preventing recurrence.
—Effectiveness Against Chemotherapy-resistant Tumors
We are developing innovative experimental drugs for cancer treatment.